Cardiovascular Drugs and Therapy
Published by Springer Nature
ISSN : 0920-3206 eISSN : 1573-7241
Abbreviation : Cardiovasc. Drug Ther.
Aims & Scope
Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.
Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias.
The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.
Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services.
The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field.
Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 3.1 |
| 2024 | 3.10 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.002 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 83 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 4814 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 1207 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study
Citation: 982
Authors: Eric, Gilles, Sylvie, Caroline, Bernard
-
Anthracycline Chemotherapy and Cardiotoxicity
Citation: 759
Authors: John V, Robin, Angshuman, Izabela, J Malcolm, Derek M
-
Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4
Citation: 374
Authors: Ram B., Mohammad A., Jagdish P., Rakesh, Vipul, M.
-
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor
Citation: 325
Authors: Yumei, Mandeep, Hsiu-Chiung, Jose R., Yochai
-
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Citation: 303
Authors: Anis, Nikolaos G.
-
Necrostatin: A Potentially Novel Cardioprotective Agent?
Citation: 291
Authors: Christopher C. T., Sean M., Shiang Y., James C., John S., Derek M.
-
The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction
Citation: 284
Authors: Bertram, Gordon, Willem, Felipe, Jose, Faiez, James, Barbara, Steve, Dan, Richard, Jay